The GATRA is a program whose aim is to identify and support innovative clinical and scientific research aimed at gaining more insight into the current and new uses of Antithrombin.
By supporting this program Grifols demonstrates its commitment to innovation in this field. We consider the program to be a tangible contribution to the improvement of standards and benefits for the patient care
2019-2020 cycle application now open
Given the exceptional situation with the COVID-19 pandemic, the deadline for submission of Letters of Intent has been postponed until June 30th
Please click here to apply